These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10974627)

  • 1. Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide.
    Osoba D; Brada M; Yung WK; Prados MD
    Eur J Cancer; 2000 Sep; 36(14):1788-95. PubMed ID: 10974627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.
    Osoba D; Brada M; Yung WK; Prados M
    J Clin Oncol; 2000 Apr; 18(7):1481-91. PubMed ID: 10735896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.
    Minniti G; Scaringi C; Baldoni A; Lanzetta G; De Sanctis V; Esposito V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):285-91. PubMed ID: 23642624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
    Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
    J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
    Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W; Glantz M; Greenberg H; Selker RG; Vick NA; Rampling R; Friedman H; Phillips P; Bruner J; Yue N; Osoba D; Zaknoen S; Levin VA
    Br J Cancer; 2000 Sep; 83(5):588-93. PubMed ID: 10944597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine.
    Kiebert GM; Jonas DL; Middleton MR
    Cancer Invest; 2003; 21(6):821-9. PubMed ID: 14735685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of health related quality of life in patients with recurrent glioma treated with bevacizumab plus daily temozolomide as the salvage therapy.
    Liu Y; Feng F; Ji P; Liu B; Ge S; Yang C; Lou M; Liu J; Li B; Gao G; Qu Y; Wang L
    Clin Neurol Neurosurg; 2018 Jun; 169():64-70. PubMed ID: 29631109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
    Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma.
    Chamberlain MC; Tsao-Wei DD; Groshen S
    Cancer; 2006 Jan; 106(1):172-9. PubMed ID: 16323194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
    Chinot OL; Honore S; Dufour H; Barrie M; Figarella-Branger D; Muracciole X; Braguer D; Martin PM; Grisoli F
    J Clin Oncol; 2001 May; 19(9):2449-55. PubMed ID: 11331324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
    Taphoorn MJ; Stupp R; Coens C; Osoba D; Kortmann R; van den Bent MJ; Mason W; Mirimanoff RO; Baumert BG; Eisenhauer E; Forsyth P; Bottomley A; ; ;
    Lancet Oncol; 2005 Dec; 6(12):937-44. PubMed ID: 16321761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
    Zheludkova OG; Tarasova IS; Gorbatykh SV; Belogurova MB; Kumirova EV; Borodina ID; Prityko AG; Melikian AG; Shcherbenko OI
    Vopr Onkol; 2002; 48(3):356-60. PubMed ID: 12455362
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage temozolomide for prior temozolomide responders.
    Franceschi E; Omuro AM; Lassman AB; Demopoulos A; Nolan C; Abrey LE
    Cancer; 2005 Dec; 104(11):2473-6. PubMed ID: 16270316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.
    Ahluwalia MS; Xie H; Dahiya S; Hashemi-Sadraei N; Schiff D; Fisher PG; Chamberlain MC; Pannullo S; Newton HB; Brewer C; Wood L; Prayson R; Elson P; Peereboom DM
    J Neurooncol; 2015 Mar; 122(1):111-9. PubMed ID: 25534576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
    Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
    Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide for recurrent high-grade glioma.
    Macdonald DR
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):3-12. PubMed ID: 11550133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.
    Sadones J; Michotte A; Veld P; Chaskis C; Sciot R; Menten J; Joossens EJ; Strauven T; D'Hondt LA; Sartenaer D; Califice SF; Bierau K; Svensson C; De Grève J; Neyns B
    Eur J Cancer; 2009 Jan; 45(1):146-53. PubMed ID: 18945611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.